High blood pressure, or hypertension, can be defined as the flow of blood through the arteries being pushed against the inside of the artery walls. The more pressure the blood exerts on the artery walls, the higher the blood pressure. Hypertension has been labelled the silent killer – as it rarely has symptoms. As such, […]
Read More
A recent article published in PharmAsia News highlighted the results of ground-breaking research, published in The New England Journal of Medicine (NEJM), that showed a lower dose of intravenous alteplase can reduce bleeds in the brain and improve survival rates in patients with acute ischemic stroke. While the results of ENCHANTED, a predominantly Asian study, […]
Read More
The Malaysian government has committed funding to improve the healthcare systems in order to further support clinical research. Clinical Research Malaysia (CRM) is a non-pro t organisation – wholly owned by the government of Malaysia, which intends to develop infrastructure for the Clinical Research Centre networks, and be able to support global industry sponsored research […]
Read More
Philip Gregory of George Clinical – China, highlight South Korea’s capabilities in a three part series originally published on http://innovations.bbkworldwide.com/part-ii-insights-on-the-clinical-trial-landscape-of-south-korea. He provides insight on its recent clinical research developments that are driving innovation across the Asia-Pacific region. South Korea In comparison to Japan, South Korea has had a longer history of conducting global clinical trials. In fact, more than […]
Read More
Philip Gregory of George Clinical focuses on China, in a three part series originally published on http://innovations.bbkworldwide.com/part-iii-chinas-future-in-global-clinical-research that discusses developments in the clinical trial landscape of East Asia and Japan. Active international collaboration has facilitated the rise of the Asia-Pacific region in global clinical research. With the world’s largest population, China’s recent changes to their clinical trial processes and […]
Read MoreSponsors are increasingly seeking emerging areas to conduct clinical trials for new patient pools and better recruitment. However, successful implementation of a global clinical trial in areas such as South East Asia requires operational strategies that circumvents the inherent diversity of these regions. In these regions, language, culture, infrastructure and resources are very different from […]
Read More
Throughout clinical trials, the data manager (DM) is heavily involved in constructing databases, managing reports, programming quality checks and managing the collection of data in the clinical trial. The DM is responsible for managing and training users the concepts of computerised clinical data base systems as well as fulfilling other duties such as design basic […]
Read More
The Malaysian government has committed funding to improve the healthcare systems in order to further support clinical research. Clinical Research Malaysia (CRM) is a non-profit organisation – wholly owned by the government of Malaysia, which intends to develop infrastructure for the Clinical Research Centre networks, and be able to support global industry sponsored research (ISR) […]
Read More
George Clinical (GC) conducted a brief survey on sponsors who are currently not a customer of GC. 30 companies were surveyed by GC’s Business Development Managers across six countries which included the United States, China, Australia, Korea, United Kingdom and Israel. The primary objective of the survey was to determine the services and countries that were important […]
Read More
The cost of employee turnover in a Clinical Research Organisation (CRO) is high, as it weakens the relationship with the project sponsor. Research shows that in 2012, the CRO industry in the United States experienced a 12.5% voluntary turnover, compared to an average national voluntary turnover rate of 1.5%. During the 2015 financial year, George Clinical […]
Read More
